Condition
Shy-Drager Syndrome
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
Early P 1 (2)
P 1 (1)
Trial Status
Completed2
Terminated2
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02194816Recruiting
Modifiable Variables in Parkinsonism (MVP)
NCT02149901Early Phase 1TerminatedPrimary
Water and Sudafed in Autonomic Failure
NCT02591173Early Phase 1Terminated
Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
NCT00179023Phase 1Completed
The Autonomic Nervous System and Obesity
NCT00004478Not ApplicableCompletedPrimary
Droxidopa in Treating Patients With Neurogenic Hypotension
Showing all 5 trials